Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Clavis Pharma ASA : Clavis Pharma ASA : Recommendation by the Election Committee



    Clavis Pharma ASA : Clavis Pharma ASA : Recommendation by the Election
                                  Committee

Oslo, Norway, 22 April 2013

To the Shareholders of Clavis Pharma ASA

Reference is made to the announcement on 11 April 2013 regarding the
Extraordinary General Meeting in Clavis Pharma ASA to elect a new Board of
Directors. At the time of the announcement, the Election Committee had not
concluded on its recommendation for new members  for the Board of Directors.
The Election Committee's recommendation has now been finalized - please refer
to the attachment.

Contact:
Gunnar Manum
Chief Financial Officer
+47 24 11 09 71
+47 95 17 91 90 (mob)
gunnar.manum@clavispharma.com

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Recommendation by the Election Committee

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Clavis Pharma ASA via Thomson Reuters ONE
HUG#1694833
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement